88 results match your criteria: "Saka General Hospital.[Affiliation]"

Background: In the first-line treatment of elderly patients with advanced-stage non-small cell lung cancer (NSCLC) with high programmed death-ligand 1 (PD-L1) expression (tumor proportion score ≥ 50%), this study aimed to determine whether pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum-based chemotherapy (COMB) should be selected.

Methods: We performed a retrospective multicenter study (sub-analysis of the HOT/NJLCG2001 trial) of 299 patients with NSCLC with high PD-L1 expression who received MONO or COMB as the first-line treatment between December 2018 and January 2020. We selected patients aged 75 years and older and assessed the clinical efficacy and toxicity.

View Article and Find Full Text PDF

Background: Respiratory syncytial virus (RSV) is a leading cause of acute respiratory illness, with severe outcomes in older adults. Information on the prevalence, hospitalization rate, and impact on the health-related quality of life (HRQoL) of RSV in older adults with acute respiratory infections (ARI) in outpatient settings in Japan is limited.

Methods: This multi-center epidemiological study included outpatients aged ≥60 years presenting with ARI between August 2021 and February 2023.

View Article and Find Full Text PDF

Objective: This study aimed to determine the impact of infrapopliteal (IP) revascularisation establishing in line flow to the wound (IFW) on wound healing in chronic limb threatening ischaemia (CLTI), using a core laboratory assessment for wounds and in line flow.

Methods: The Wound directed Angiosome RevasculaRIsation apprOach to patients with cRitical limb iSchaemia (WARRIORS) multicentre observational study enrolled patients with CLTI with tissue loss undergoing IP revascularisation in Japan, with scheduled two year follow up. The primary outcome measure was complete wound healing, defined as achievement of complete epithelialisation of all wounds without major amputation.

View Article and Find Full Text PDF
Article Synopsis
  • EGFR-TKIs like afatinib and osimertinib are effective for treating non-small cell lung cancer with EGFR mutations, but high PD-L1 levels may lead to poorer responses.
  • A study analyzed 177 patients with PD-L1-positive EGFR-mutant NSCLC to compare the effectiveness of afatinib versus osimertinib.
  • The findings indicated no significant difference in progression risk or overall survival between the two treatments, suggesting similar effectiveness for patients with this specific cancer profile.
View Article and Find Full Text PDF
Article Synopsis
  • Sarcopenia, the loss of muscle mass and strength, affects both adults and children, but its definitions and diagnostic criteria in pediatrics are not well-established, complicating interventions.
  • A scoping review of existing literature identified 56 relevant studies on pediatric sarcopenia, noting that skeletal muscle mass is often measured by imaging techniques, although methods for diagnosing sarcopenia vary widely.
  • The review concluded that while there is a correlation between sarcopenia and negative health outcomes in children, the absence of standardized cutoff values highlights a need for age, gender, and race-specific metrics for future assessment and intervention.
View Article and Find Full Text PDF
Article Synopsis
  • Immune-related adverse events (irAEs) can influence the effectiveness of PD-L1 inhibitors in treating metastatic non-small cell lung cancer (NSCLC), but their impact on nonmetastatic NSCLC outcomes was previously unclear.
  • This study evaluated the relationship between irAEs and progression-free survival (PFS) in Stage III NSCLC patients undergoing treatment with the PACIFIC regimen, analyzing both mild and nonmild irAEs through robust statistical methods.
  • Findings indicated that patients with nonmild irAEs experienced poorer PFS compared to those with mild irAEs or none at all, suggesting that mild irAEs could indicate better survival outcomes while more severe reactions treated with steroids are linked to worse outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - A 76-year-old man with lung cancer received atezolizumab, a PD-L1 inhibitor, but developed fatigue and was diagnosed with atezolizumab-induced sclerosing cholangitis shortly after treatment.
  • - He was treated with steroids, leading to improvement in his symptoms and laboratory results, although he faced complications like liver abscesses later on.
  • - The case highlights the rarity and potential severity of sclerosing cholangitis as a side effect of immune checkpoint inhibitors, underscoring the need for awareness regarding this condition in clinical practice.
View Article and Find Full Text PDF

Purpose: Surgical thromboendarterectomy has been the gold standard treatment for common femoral artery (CFA) disease. However, endovascular therapy (EVT) is conducted in certain patients with CFA lesions because of multiple comorbidities. The interwoven nitinol stent (IWS) has been developed to prevent stent fracture.

View Article and Find Full Text PDF

Psychological aspects of rehabilitation nutrition affect physical, cognitive, and social rehabilitation nutrition. When depression is recognized, not only pharmacotherapy and psychotherapy, but also non-pharmacological therapies such as exercise, nutrition, psychosocial, and other interventions can be expected to improve depression. Therefore, accurate diagnosis and intervention without overlooking depression is important.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated acute acalculous cholecystitis, focusing on its incidence, treatment options, and patient outcomes.
  • Researchers collected data on 432 patients over a three-year period, revealing that this condition represents 7.04% of all acute cholecystitis cases, with varying severity levels based on the Tokyo guidelines.
  • The findings suggest that laparoscopic cholecystectomy is the most effective treatment, particularly for mild to moderate cases, while severe cases may require immediate surgical intervention.
View Article and Find Full Text PDF
Article Synopsis
  • A phase 2 trial tested the combination of docetaxel and ramucirumab with pegylated-granulocyte-colony stimulating factor (PEG-G-CSF) in elderly, chemo-naive patients (aged 75+) with advanced non-small cell lung cancer (NSCLC) to reduce the risk of febrile neutropenia (FN).
  • Out of 54 enrolled patients, the overall response rate (ORR) was 38.9% with a substantial disease control rate of 79.6%, while the median progression-free survival and overall survival were 5.2 and 12.7 months, respectively.
  • The treatment demonstrated a favorable safety profile, with a low occurrence of FN (
View Article and Find Full Text PDF

Aetiological agents of adult community-acquired pneumonia in Japan: systematic review and meta-analysis of published data.

BMJ Open Respir Res

September 2023

Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan.

Objective: Epidemiological information is essential in providing appropriate empiric antimicrobial therapy for pneumonia. This study aimed to clarify the epidemiology of community-acquired pneumonia (CAP) by conducting a systematic review of published studies in Japan.

Design: Systematic review.

View Article and Find Full Text PDF

Background: Drug-coated balloons (DCBs) have significantly changed endovascular therapy (EVT) for femoropopliteal artery (FPA) disease, in terms of the expansion of indications for EVT for symptomatic lower extremity arterial disease (LEAD). However, whether there is a difference in the performance among individual DCBs has not yet been fully discussed. The present sub-analysis of real-world data from a prospective trial of first-generation DCBs compared the clinical outcomes between high- and low-dose DCBs using propensity score matching methods.

View Article and Find Full Text PDF

Purpose: To investigate the 1-year and 2-year clinical outcomes of interwoven stent (IWS) implantation for symptomatic femoropopliteal arterial disease with calcification.

Material And Methods: This prospective multicenter study evaluated 308 limbs (63% with the peripheral arterial calcium scoring system 3 and 4 severe calcification and 87% with ≥180° calcification on intravascular ultrasound) of 299 patients (diabetes in 66.9%, chronic renal failure in 52.

View Article and Find Full Text PDF
Article Synopsis
  • * Data from 263 patients were analyzed, showing combined therapy resulted in a lower risk of cancer progression (hazard ratio of 0.47) compared to first- and second-generation EGFR-TKIs.
  • * The results suggest that combined therapy may offer a promising treatment option for NSCLC patients, as it shows improved progression-free survival compared to EGFR-TKI alone.
View Article and Find Full Text PDF
Article Synopsis
  • The PACIFIC regimen, which involves durvalumab treatment after chemoradiation, is standard for unresectable stage III NSCLC, but many patients see disease progression within a year, highlighting a need to understand treatment resistance.
  • A study involving 135 patients aimed to analyze tumor microenvironments and immune cell profiles to identify resistance mechanisms, revealing key findings related to adaptive immunity and specific cancer cell behaviors.
  • Results showed that low levels of CD8 lymphocytes and high CD73 expression in tumors correlate with poor treatment outcomes, suggesting that targeting CD73 may improve future therapies and highlighting the role of adaptive immunity in treatment effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • A nationwide surveillance study in Japan assessed the antimicrobial susceptibility of bacterial pathogens related to respiratory tract infections, collecting data from June 2019 to December 2020.
  • The study analyzed 932 bacterial strains from 32 medical facilities, finding notable resistance rates, such as 35.3% for methicillin-resistant Staphylococcus aureus and 16.2% for β-lactamase-producing resistant Haemophilus influenzae.
  • Results from this surveillance aim to inform treatment strategies for respiratory infections in Japan and promote the responsible use of antimicrobial drugs.
View Article and Find Full Text PDF

Recent advances in the development of chemotherapies have helped improve the prognosis of pancreatic ductal adenocarcinoma (PDAC). However, predicting factors for the outcomes of chemotherapies (either gemcitabine or S-1) have not yet been established. We analyzed the expression of 4 major epithelial-to-mesenchymal transition-inducing transcription factors in 38 PDAC patients who received adjuvant chemotherapy after radical resection to examine the association with patients' prognoses.

View Article and Find Full Text PDF

We defined respiratory sarcopenia as a coexistence of respiratory muscle weakness and decreased respiratory muscle mass. Although respiratory muscle function is indispensable for life support, its evaluation has not been included in the regular assessment of respiratory function or adequately evaluated in clinical practice. Considering this situation, we prepared a position paper outlining basic knowledge, diagnostic and assessment methods, mechanisms, involvement in respiratory diseases, intervention and treatment methods, and future perspectives on respiratory sarcopenia, and summarized the current consensus on respiratory sarcopenia.

View Article and Find Full Text PDF

Introduction: Pembrolizumab is a programmed death-ligand 1 inhibitor that was initially indicated for monotherapy in patients with advanced lung cancer. The Japanese Lung Cancer Society conducted an observational study on pembrolizumab using confirmative data obtained through postmarketing all-case surveillance (PMACS), which was performed by a pharmaceutical company under the Japanese law in 2017.

Methods: This multicenter observational study was conducted by the Japanese Lung Cancer Society using PMACS data with the newly created central registration system regarding patients with NSCLC who received pembrolizumab monotherapy between February 1, 2017 and June 30, 2017; a new database was created by adding the clinical information regarding prognosis for 3 years after therapy to the existing data collected by PMACS.

View Article and Find Full Text PDF

Acute cytomegalovirus infection in a 61-year-old woman.

CMAJ

August 2022

Department of General Practice (Hongo), Saka General Hospital, Miyagi, Japan; Department of Diagnostic and Generalist Medicine (Harada, Shimizu), Dokkyo Medical University, Mibu, Shimotsugagun, Tochigi, Japan; Department of Infectious Diseases (Gu), Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

View Article and Find Full Text PDF

Introduction: Malignant tumors are the major cause of death in hemodialysis patients. Management of these patients remains challenging as there is no evidence that chemotherapy is beneficial, and a lack of information about actual clinical practice.

Methods: This multicenter retrospective study included hemodialysis patients who were diagnosed with lung cancer from January 2002 to June 2018.

View Article and Find Full Text PDF

Background: To detect human metapneumovirus, tests besides reverse transcription-polymerase chain reaction (RT-PCR) on nasopharyngeal swab specimens are less accessible. Immunochromatography assays are rapid and simple without the need of any special equipment but sometimes are insufficiently sensitive. This study describes the usefulness of immunochromatography assays to detect human metapneumovirus in adult patients with human metapneumovirus-related acute lower respiratory tract infection using sputum specimens.

View Article and Find Full Text PDF

We experienced a patient with pneumonia developing immediately after discharge from COVID-19 recovery. Antibiotic treatment was successful. The source of infection was proven to be bathtub water in this case.

View Article and Find Full Text PDF